Manufacturing Associate Intern – Winslow, Maine (Summer 2027)
Elanco
Summary
As a Summer 2027 Technical Services and Manufacturing Sciences (TSMS) Intern with Elanco Animal Health, you will be part of the TSMS team at our Winslow, Maine manufacturing plant, contributing to a hands-on technical project focused on improving processes, solving business challenges, and supporting operational and technical excellence.
Job description
Your Responsibilities
- Understand the Animal Health Manufacturing process, document using GMP guidelines, and understand the importance of the Quality Unit
- Work within cross-functional teams to implement processes or lab improvements
- Learn about upstream antigen manufacturing (i.e. fermentation, viral manufacturing), downstream manufacturing (i.e. lyophilization and blending), quality control, sterility assurance, or vaccine packaging.
- Study design improvement processes
What You Need to Succeed (minimum qualifications)
- Education: Currently enrolled in a Life Sciences major or an Engineering major including (but not limited to) Chemical, Mechanical, Electrical, or Process
- Top Skills: Experience in Microsoft Suites and a willingness to learn
What will give you a competitive edge (preferred qualifications)
- Prior internship or professional experience in a life-science industry
- Strong communication and interpersonal skills
- Strong organizational and time management skills
- Must be able to work exceptionally well independently and with minimal supervision
Additional Information
- Travel: 10% - to corporate facility in Indianapolis, IN for opening/closing
- Location: Winslow Manufacturing Plant, Winslow, ME
Requirements
- Currently enrolled in a Life Sciences major or an Engineering major including (but not limited to) Chemical, Mechanical, Electrical, or Process
- Experience in Microsoft Suites and a willingness to learn
Benefits
- Housing support
- Mentorship program
- Networking events
- Learning resources
Company overview
Elanco Animal Health Incorporated is a global leader in the animal health pharmaceutical industry, dedicated to improving the health and well-being of both pets and farm animals worldwide. Founded in 1954 as a division of Eli Lilly and Company, Elanco became an independent public company in 2018 and has since grown to become the world's second-largest independent animal health company. With approximately 9,000 employees globally, the company operates with a clear purpose: 'making life better for animals, makes life better.' Elanco develops innovative medicines, vaccines, and health solutions that empower veterinarians, farmers, and pet owners to advance animal care. The company maintains a balanced portfolio between pet health and farm animal products, offering over 200 brands that address critical health challenges ranging from companion animal diseases to livestock productivity. Headquartered in Indianapolis, Indiana, Elanco is publicly traded on the New York Stock Exchange (NYSE: ELAN) and continues to drive innovation in animal health through strategic acquisitions and dedicated research and development efforts.